Description

Epirubicin Amaxa (epirubicin) solution for injections 2 mg/ml. 10 ml. vial №1

Ingredients

Epirubicin is the active ingredient in Epirubicin Amaxa. Each ml of the solution contains 2 mg of epirubicin hydrochloride.

Dosage

The dosage of Epirubicin Amaxa should be determined by a healthcare professional based on individual factors such as body weight, overall health, and the specific condition being treated. It is typically administered intravenously over a specific period.

Indications

Epirubicin Amaxa is indicated for the treatment of various cancers, including breast cancer, ovarian cancer, and stomach cancer. It works by interfering with the growth and spread of cancer cells in the body.

Contraindications

Do not use Epirubicin Amaxa if you are allergic to epirubicin or any of the other ingredients in the solution. It is important to discuss any existing medical conditions or medications with your healthcare provider before starting treatment.

Directions

Epirubicin Amaxa should only be administered by healthcare professionals experienced in the use of chemotherapy drugs. The solution is typically given as a slow injection into a vein. Follow all instructions provided by your healthcare team.

Scientific Evidence

Epirubicin, the active ingredient in Epirubicin Amaxa, has been extensively studied for its efficacy in treating various types of cancer. Research studies have shown that epirubicin works by inhibiting DNA and RNA synthesis in cancer cells, leading to cell death. Clinical trials have demonstrated the effectiveness of epirubicin in improving survival rates and reducing tumor size in patients with advanced cancers.

Additional Information

In addition to its anti-cancer effects, Epirubicin Amaxa may cause side effects such as nausea, vomiting, and hair loss. It is important to discuss potential side effects and monitoring options with your healthcare provider. Regular blood tests may be required to monitor your body’s response to the treatment.

Pharmacologically, Epirubicin Amaxa belongs to the class of anthracycline antibiotics. It exerts its cytotoxic effects by intercalating DNA strands and inhibiting topoisomerase II, leading to DNA damage and cell death. This mechanism of action makes it a valuable component in the treatment of various cancers.

Comparative studies have shown that Epirubicin Amaxa demonstrates similar efficacy to other anthracycline drugs while potentially offering a more favorable safety profile. Its use in combination therapies has also been investigated, showing promising results in improving treatment outcomes and reducing the risk of resistance development.